The University of Colorado Anschutz Medical Campus has come together (UC Health, Children’s Hospital Colorado, and the University of Colorado Anschutz) to architect and build a premier nationally-recognized healthcare innovation ecosystem. Initiated in 2016, this ecosystem actively collaborates with leading startups as well as other large stakeholders including payers, pharma, and technologies companies to push the boundaries in healthcare. The opportunity for value creation at the intersection of these collaborations is significant and in response, we have formed the CU Healthcare Innovation Fund to capitalize on our own innovation activities and unique deal flow.

The CU Healthcare Innovation Fund is a strategic healthcare fund affiliated with the University of Colorado Anschutz Medical Campus that invests in ventures across the healthcare spectrum (healthcare IT, tech enabled services, and selectively in high-potential medical device and pharmaceutical technologies). Its close affiliation with the campus provides access to a unique pipeline of opportunities that have been financially and operationally de-risked by leveraging the assets of the Anschutz Medical Campus prior to investment. This provides an advantage over traditional healthcare funds, allows the fund to capture the upside with less risk, and provides investors with the opportunity to earn market leading returns while having a positive impact on healthcare. As a strategic health system investor, the Fund will co-invest with other strategic investors who create additional momentum for our companies such as payers, other health systems, pharma, tech and traditional healthcare-focused venture capital investors.

The Fund management and investment advisory board is comprised of a nationally recognized team of healthcare entrepreneurs, investors, and innovation thought leaders with 200+ years of experience in biotechnology and digital health representing over $30B+ in value creation. 

  • Over 500+ companies evaluated nationally
  • Strong pipeline of de-risked companies ready to scale
  • Fund invests in top 1% of pipeline companies
  • Strategic relationships with 10+ multinational healthcare corporations
  • Currently $16M assets under management